Skip to main content
. 2021 Sep 3;41(8):1878–1892. doi: 10.1007/s10875-021-01090-8

Table 2.

A-T patients from the Frankfurt cohort

All patients no deficient IgA (IgA ≥ 0.07 g/L) IgA deficient (IgA < 0.07 g/L) P value
No. of patients (n) 66 31 35
Age (years) 12 (1–39) 15 (2–39) 10 (1–38) n.s
Sex (M/F) 35/31 16/15 19/16
IgA (g/L) 0.06 (0.002–2.25) 11.0 (0.3–2.25) 0.05 (0.002–0.06) 0.0001
IgG (g/L) 8.70 (0.66–21.5) 8.34 (3.96–21.5) 9.01 (0.66–20.6) n.s
IgG2 (g/L) 0.69 (0.11–6.98) 0.64 (0.12–2.76) 0.82 (0.11–6.98) n.s
IgG4 (g/L) 0.02 (0.00–0.42) 0.03 (0.00–0.42) 0.02 (0.00–0.23) n.s
IgM (g/L) 1.53 (0.17–5.45) 1.67 (0.72–5.45) 1.19 (0.17–2.73) n.s
Lymphocytes (cells/µL) 1335 (180–3660) 1608 (595–3660) 1142 (180–2700) 0.01
α-feto-protein (ng/mL) 278 (28.7–1264) 266 (28.7–1264) 332 (49–1044) n.s
CRP§ 18 4 14 0.05
Granulomas 8 1 7 0.058

* included patients with partial IgA-D (n = 7), all of them aged above 12 years of age and an IgA level > 0.3 g/L. § number of episodes with a significant elevation of CRP > 2 mg/dL